# Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

> **NCT03027674** · EARLY_PHASE1 · COMPLETED · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 10 (actual)

## Conditions studied

- Raynaud Phenomenon Due to Trauma
- Raynaud Disease
- System; Sclerosis
- Lupus Erythematosus, Systemic
- Dermatomyositis
- Ultrasound Therapy; Complications

## Interventions

- **DRUG:** 10% nifedipine cream
- **DRUG:** 5% sildenafil cream

## Key facts

- **NCT ID:** NCT03027674
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03027674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03027674, "Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03027674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*